Повышение гемоглобина у детей



Номер журнала: декабрь 2010

Повышение гемоглобина у детей

Э.К.Петросян, П.В.Шумилов, А.П.Пономарева, О.С.Татаренова, Л.М.Карпина, М.Б.Сагалович, Ю.Г.Мухина
ГОУ ВПО Российский государственный медуниверситет Росздрава, Москва
Русский детская клиническая поликлиника, Москва

Кровь в стуле у детей есть важным симптомом ряда серьёзных болезней. Появление крови в стуле требует расширенного клинического и инструментального обследования и проведения детальной дифференциальной диагностики. В детском возрасте частота данного симптома мала. Кровь в стуле отмечается у 0,3% детей, поступающих в стационар [1].

Повышение гемоглобина у детей

Литература
1. Arvola T. Ruuska T. Keranen J. Hyoty H. Salminen S. Isolauri E. Rectal Bleeding in Infancy: Clinical, Allergological, and Microbiological Examination. Pediatrics. 2006; 117: e760-e768.
2. Buller H. Chin S. Kirschner B. Kohn J. Markowitz J. Moore D. Murch S. Taminiau J. Inflammatory bowel disease in children and adolescents: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J. Pediatr. Gastroenterol. Nutr. 2002; 35: 151-158.
3. Stichweh D. Arce E. Pascual V. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol. 2004; 16: 577-87.
4. Tucker L.B. Menon S. Schaller J.G. Isenberg D.A. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol. 1995 Sep; 34 (9): 866-72.
5. Rood M.J. ten Cate R. van Suijlekom-Smit L.W. et al. Childhood-onset кожный покров Lupus Erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol. 1999; 28 (4): 222-6.
6. Marks S.D. Hiraki L. Hagelberg S. Silverman E.D. Hebert D. Age-related renal prognosis of childhood-onset SLE. Pediatr Nephrol. 2002; 17 (9): 107.
7. Dale R.C. Tang S.P. Heckmatt J.Z. Tatnall F.M. Familial systemic lupus erythematosus and congenital infection-like syndrome. Neuropediatrics. 2000 Jun; 31 (3): 155-8.
8. Zulian F. Pluchinotta F. Martini G. Da Dalt L. Zacchello G. Severe clinical course of systemic lupus erythematosus in the first year of life. Lupus. 2008 Sep; 17 (9):780-6.
9. Gutierrez-Suarez R. Ruperto N. Gastaldi R. et al. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 2006 Sep; 54 (9): 2989-96.
10. Jacobsen S. Petersen J. Ullman S. et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol. 1998; 17 (6): 478-84.
 11. Cervera R. Khamashta M.A. Font J. et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003 Sep; 82 (5): 299-308.
12. Moradinejad M.H. Zamani G.R. Kiani A.R. Esfahani T. Clinical features of juvenile lupus erythematosus in Iranian children. Acta Reumatol Port. 2008 Jan-Mar; 33 (1): 63-7.
13. Bader-Meunier B. Armengaud J.B. Haddad E. et al. Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr. 2005 May; 146 (5): 648-53.
14. Supavekin S. Chatchomchuan W. Pattaragarn A. Suntornpoch V. Sumboonnanonda A. Pediatric systemic lupus erythematosus in Siriraj Hospital. J Med Assoc Thai. 2005 Nov; 88 Suppl 8: S115-23.
15. Dubois E.L. Tuffanelli D.L. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA. 1964 Oct 12; 190: 104-11.
16. Hallegua D.S. Wallace D.J. Gastrointestinal manifestations of systemic lupus erythematosus. Curr Opin Rheumatol. 2000; 12: 379-85.
17. Sultan S.M. Ioannou Y. Isenberg D.A. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology. 1999; 38: 917-32.
18. Richer O. Ulinski T. Lemelle I. et al. Abdominal manifestations in childhood-onset systemic lupus erythematosus. Ann Rheum Dis. 2007 Feb; 66 (2): 174-8.
19. Jessar R. Lamont-Havers R. Ragar C. Natural history of lupus erythematosus disseminatus. Ann. Intern. Med. 1953; 38: 717-29.
20. Harvey A.M. Shulman L.E. Tumulty P.A. Conley C.L. Schoenrich E.H. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore). 1954 Dec; 33 (4): 291-437.
21. Dubois E.L. Wierzchowiecki M. Cox M.B. Weiner J.M. Duration and death in systemic lupus erythematosus. An analysis of 249 cases. JAMA. 1974 Mar 25; 227 (12): 1399-402.
22. Fries J. Holman H.R. Systemic lupus erythematosus: a clinical analysis. Philadelphia: WB Saundres, 1975.
23. Xu D. Yang H. Lai C.C. et. al. Clinical analysis of systemic lupus erythematosus with gastrointestinal manifestations. Lupus. 2010 Apr 21. [Epub ahead of print].
24. Brown C.H. Haserick J.R. Shirey E.K. Chronic ulcerative colitis with systemic lupus erythematosus; report of a case. Cleve Clin Q. 1956 Jan; 23 (1): 43-6.
25. Kurlander D.J. Kirsner J.B. The association of chronic nonspecific inflammatory bowel disease with lupus erythematosus. Ann Intern Med. 1964 May; 60: 799-813.
26. Stevens H.P. Ostlere L.S. Rustin M.H. Systemic lupus erythematosus in association with ulcerative colitis: related autoimmune diseases. Br J Dermatol. 1994 Mar; 130 (3): 385-9.
27. Siurala M. Julkunen H. Toivonen S. Pelkonen R. Saxen E. Pitkaenen E. Digestive tract in collagen diseases. Acta Med Scand. 1965 Jul; 178: 13-25.
28. Bazinet P. Marin G.A. Malabsorption in systemic lupus erythematosus. Am J Dig Dis. 1971 May; 16 (5): 460-6.
29. Nadorra R.L. Nakazato Y. Landing B.H. Pathologic features of gastrointestinal tract lesions in childhood-onset systemic lupus erythematosus: study of 26 patients, with review of the literature. Pediatr Pathol. 1987; 7 (3): 245-59.
30. Dalekos G.N. Manoussakis M.N. Goussia A.C. Tsianos E.V. Moutsopoulos H.M. Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis. Gut. 1993 May; 34 (5): 658-64.
31. Молчанов И.В. Гольдина О.А. Горбачевский Ю.В. Растворы гидроксиэтилкрахмала современные и действенные плазмозамещающие средства инфузионной
терапии. М. НЦССХ, 1998; 138.
32. Webb A.R. Moss R.F. Tighe D. A narrow range, medium molecularweight pentastarch reduces structural organ damagein model of sepsis. Int Care Med. 1992; 18: 348-55.

Статьи по теме